Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic E...
Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
About this item
Full title
Author / Creator
Mike, Jana Krystofova , White, Yasmine , Hutchings, Rachel S. , Vento, Christian , Ha, Janica , Iranmahboub, Ariana , Manzoor, Hadiya , Gunewardena, Anya , Cheah, Cheryl , Wang, Aijun , Goudy, Brian D. , Lakshminrusimha, Satyan , Long-Boyle, Janel , Fineman, Jeffrey R. , Ferriero, Donna M. and Maltepe, Emin
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Originally approved by the U.S. Food and Drug Administration (FDA) for its antihistamine properties, clemastine can also promote white matter integrity and has shown promise in the treatment of demyelinating diseases such as multiple sclerosis. Here, we conducted an in-depth analysis of the feasibility, safety, and neuroprotective efficacy of clema...
Alternative Titles
Full title
Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f94acf4a9f4548449f83fd47924aaad4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f94acf4a9f4548449f83fd47924aaad4
Other Identifiers
ISSN
2227-9067
E-ISSN
2227-9067
DOI
10.3390/children10111728
